Medical Devices Startups

CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.

1 investor

Corventum is a biopharmaceutical company developing therapies that protect the heart from the toxic effects of cancer treatment, allowing patients to continue first-line oncology therapy. Its lead program, CVT-130, is a small molecule for the prevention of anthracycline cardiotoxicity, advancing into the clinic in 2026.

1 investor

Corvita develops automated external defibrillator (AED) solutions addressing gaps in emergency medical equipment for healthcare settings. The company combines hardware and management services to improve access to critical cardiac emergency response tools.

1 investor

Cosma is a women's health and fertility company that designs, manufactures and distributes non-hormonal fertility products for the Indian market, positioned as an option between unassisted conception and IVF. Its offerings include Fertigen, a CDSCO-approved Class B medical device, and FertiLens, a digital fertility assessment platform, supported by a network of fertility specialists, diagnostic labs and partner clinics.

1 investor

COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease. It also provides resources to academic researchers to help translate implantable device concepts into systems tested in first-in-human studies.

1 investor

FortisKap makes a fingerprint-secured connected cap for standard prescription vials that logs who opens a medication, when, and how many pills remain, producing time-stamped adherence data. It is aimed at patients, families, and clinicians as well as care programs to track medication access, misuse, and diversion.

1 investor

Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.

1 investor

CoTreat provides AI-powered clinical documentation and patient communication tools for dental practices, automating consultation transcription, treatment planning, and patient letters. The platform helps dentists reduce administrative time while improving patient engagement through visualizations and structured care plans.

1 investor

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS. Its genomics tools serve scientists working in biomarker analysis, gene therapeutics, and clinical diagnostics.

1 investor

Country Care Group supplies mobility and healthcare equipment and arranges in-home modifications for entitled veterans, war widow/ers and dependants under the Department of Veterans' Affairs Rehabilitation Appliances Program (RAP). It works with qualified health providers and a network of builders and tradesmen to deliver aids, appliances and home access improvements in Australia.

1 investor

Couplet Care designs the Couplet Care Bassinet, a hospital bassinet developed through human-centered research to let mothers see, reach, and interact with newborns from their hospital beds. It serves hospital postnatal units and birthing families, focusing on maternal and infant safety in postpartum maternity care.

1 investor

CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.

1 investor

Covirabio is a biotech startup developing point-of-care diagnostic test systems for detecting pathogens and monitoring immune responses, built on its VERB (Virus Entry Receptor Binding) platform that captures intact viral particles via host-pathogen interactions. Its portfolio covers SARS-CoV-2 virus detection, neutralizing-antibody immunity monitoring, and bacterial pathogen diagnosis, with assays integrated into microfluidic systems.

1 investor

CpG Diagnostics develops epigenetic diagnostic technology to detect cancer through analysis of methylation changes, with an initial focus on ovarian cancer. The platform aims to enable earlier and more accurate diagnosis for gynecologic malignancies.

1 investor

Comprehensive Prosthetics & Orthotics (CPO) is a provider of prosthetic and orthotic devices and services across the Midwest. The company operates a network of clinics in Illinois, Iowa, Indiana, and Missouri, serving amputees and patients with mobility and orthopedic conditions.

1 investor

CPR Wrap is a wearable instructional aid that guides users through cardiopulmonary resuscitation steps during cardiac emergencies. The product serves members of the general public who may need to perform CPR.

1 investor

CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.

1 investor

CQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.

1 investor

Crafton Biotechnology develops innovative mRNA-based medicines using proprietary RNA manufacturing, delivery, and synthesis technologies to create safer, scalable therapeutics for infectious diseases and rare conditions. The company focuses on overcoming key challenges in mRNA drug development including immunogenicity, manufacturing complexity, and delivery constraints.

1 investor

Create it REAL develops 3D printing technology and proprietary slicing software for sustainable, on-demand production in the orthopedic and prosthetic industries. It provides 3D printing systems and materials that let businesses produce customized products without needing prior additive manufacturing expertise.

1 investor

Creative Foam manufactures custom engineered die-cut, formed foam, nonwoven and multi-material components for the transportation, healthcare, and industrial markets. The company serves automotive, medical device, and consumer goods manufacturers across North America with production capabilities in noise reduction, sealing, welding, and protective packaging.

1 investor

Cre Medical develops transcranial focal electrical stimulation (TFS) equipment for research applications, including concentric ring electrodes and a constant-current stimulator device. The company serves research institutions and laboratories studying brain stimulation.

1 investor

Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.

1 investor

Crestec Bio develops CTB211, a redox nanoparticle (polymer micelle carrying the TEMPO nitroxide radical scavenger) originally researched at the University of Tsukuba, designed to scavenge reactive oxygen species and protect neural cells. It is being developed as a therapeutic to reduce reperfusion injury after thrombectomy in ischemic stroke patients, with a focus on brain and organ disorders.

1 investor